메뉴 건너뛰기
Emirates Medical Journal
Volumn 20, Issue 2, 2002, Pages 111-112
Gene therapy: The beginning of a medical revolution
Author keywords

[No Author keywords available]
Indexed keywords

ADENOSINE DEAMINASE; ADENOVIRUS VECTOR; CISPLATIN; FLUOROURACIL; ONYX 015; PROTEIN P53; RETROVIRUS VECTOR;
EID: 0346605840     PISSN: 02506882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)
References (8)
  • 1
    • 0018862265 scopus 로고
    • Purinogenic immunodeficiency diseases: Clinical features and molecular mechanisms
    • Mitchell BS and Kelley WN: Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms. Ann Intern Med. 1980; 92: 826-831.
    • (1980) Ann Intern Med , vol.92 , pp. 826-831
    • Mitchell, B.S.1    Kelley, W.N.2
  • 2
    • 0028807727 scopus 로고
    • T lymphocyte-directed gene therapy for ADA-deficiency SCID: Initial trial results after 4 years
    • Blaese RM, Culver KW, Miller AD, et al: T lymphocyte-directed gene therapy for ADA-deficiency SCID: Initial trial results after 4 years. Science, 1995; 270: 475-480.
    • (1995) Science , vol.270 , pp. 475-480
    • Blaese, R.M.1    Culver, K.W.2    Miller, A.D.3
  • 3
    • 0034724857 scopus 로고    scopus 로고
    • Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
    • Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 2000; 288: 669-672.
    • (2000) Science , vol.288 , pp. 669-672
    • Cavazzana-Calvo, M.1    Hacein-Bey, S.2    De Saint Basile, G.3
  • 4
    • 28644447518 scopus 로고    scopus 로고
    • Last updated November 19
    • Human Gene Therapy Protocols. Last updated November 19, 2001. OBA website: www4.od.nih.gov/oba/rac/PROTOCOL.pdf.
    • (2001) Human Gene Therapy Protocols
  • 5
    • 0033831080 scopus 로고    scopus 로고
    • A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
    • Khuri FR, Numanaitis J, Ganly I, et al: A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med, 2000; 6: 879-885.
    • (2000) Nat Med , vol.6 , pp. 879-885
    • Khuri, F.R.1    Numanaitis, J.2    Ganly, I.3
  • 6
    • 0343628721 scopus 로고    scopus 로고
    • Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin
    • May C, Rivella S, Callegari J, et al: Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature, 2000; 406: 82-86.
    • (2000) Nature , vol.406 , pp. 82-86
    • May, C.1    Rivella, S.2    Callegari, J.3
  • 7
    • 0028230779 scopus 로고
    • Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
    • Challita PM and Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA, 1994; 91: 2567-2571.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 2567-2571
    • Challita, P.M.1    Kohn, D.B.2
  • 8
    • 0025447655 scopus 로고
    • Safety considerations in somatic gene therapy of human disease with retrovirus vectors
    • Temin HM: Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther, 1990;1:111-123.
    • (1990) Hum Gene Ther , vol.1 , pp. 111-123
    • Temin, H.M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.